购物车
- 全部删除
- 您的购物车当前为空
LDC000067 (LDC067)是一种高选择性CDK9抑制剂,IC50值为44±10 nM。
为众多的药物研发团队赋能,
让新药发现更简单!
LDC000067 (LDC067)是一种高选择性CDK9抑制剂,IC50值为44±10 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 196 | 现货 | |
5 mg | ¥ 470 | 现货 | |
10 mg | ¥ 778 | 现货 | |
25 mg | ¥ 1,590 | 现货 | |
50 mg | ¥ 2,820 | 现货 | |
100 mg | ¥ 4,490 | 现货 | |
200 mg | ¥ 6,330 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 856 | 现货 |
产品描述 | LDC000067 (LDC067) is a highly specific and selective CDK9 inhibitor with an IC50 value of 44±10 nM. |
靶点活性 | CDK9:44±10 nM |
体外活性 | LDC000067 通过减少Ser2-P的水平,诱导p53激活,并在mESCs中导致细胞凋亡。此外,LDC067还能剂量依赖性地抑制P-TEFb依赖的细胞基因的de novo RNA合成。[1] |
激酶实验 | The fluorescence resonance energy transfer (FRET)-based LANCE Ultra KinaSelect Ser/Thr kit is used to determine IC50 values for various CDK inhibitors. Briefly, a specific ULight MBP peptide substrate (50 nM final concentration) is phosphorylated by a CDK-cyclin pair in buffer (50 mM HEPES-KOH pH 7.5, 10 mM MgCl2, 1 mM EGTA, 2 mM dithiothreitol) containing ATP at the concentration of the Km values of the individual kinases for 1 h at room temperature. Subsequently, phosphorylation is detected by addition of specific Eu-labelled anti-phospho-antibodies (2 nM), which upon binding to the phosphopeptide give rise to a FRET signal. FRET signals are then recorded[1]. |
别名 | LDC067, (3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺 |
分子量 | 370.43 |
分子式 | C18H18N4O3S |
CAS No. | 1073485-20-7 |
Smiles | COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1 |
密度 | 1.360 g/cm3 (Predicted) |
存储 | store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 69 mg/mL (186.3 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容